We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02964559
Brief Title: Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer

First Submitted : November 7, 2016
First Submitted that Met QC Criteria : November 11, 2016
First Posted : November 16, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 7, 2022
Last Update Posted : March 8, 2022